Medicine and Dentistry
Prostate Cancer
100%
Radiation Therapy
75%
Malignant Neoplasm
36%
Hypofractionated Radiotherapy
35%
Erectile Dysfunction
27%
External Beam Radiotherapy
23%
Sexual Dysfunction
21%
Acute Toxicity
14%
Sexual Function
14%
Quality of Life
13%
Meta-Analysis
13%
Cancer Risk
12%
Sexual Medicine
11%
Premature Ejaculation
10%
Seminal Vesicle
10%
COVID-19
10%
Second Cancer
9%
Bladder Cancer
9%
Oncology
9%
Brachytherapy
8%
Cancer
8%
Hazard Ratio
8%
Urinary System
8%
Sexual Behavior
8%
Diseases
8%
Prostatectomy
7%
Intensity Modulated Radiation Therapy
7%
Systematic Review
7%
Overall Survival
7%
Patient-Data
7%
Androgen Deprivation Therapy
7%
Patient-Reported Outcome
7%
Cohort Analysis
6%
Sexual Health
6%
Prospective Cohort Study
6%
Radiotherapy Prostate Cancer
6%
Pelvis
5%
Arm
5%
Ejaculation
5%
Cancer Therapy
5%
Intracavernous Injection
5%
Oncologist
5%
Surgical Technique
5%
Gastrointestinal Toxicity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
75%
Malignant Neoplasm
18%
Acute Toxicity
16%
Erectile Dysfunction
15%
Sexual Dysfunction
9%
Second Cancer
9%
Gastrointestinal Toxicity
8%
Androgen
8%
Diseases
8%
Rectum Hemorrhage
7%
Overall Survival
7%
Cohort Study
7%
Bladder Cancer
6%
Prospective Cohort Study
6%
Standardized Incidence Ratio
5%